High-powered holmium and thulium laser platforms are expanding ureteroscopic options for complex patients, including those on anticoagulation, while emerging technologies such as Break Wave ...
FDA 510(k) clearance enables use of external neuromuscular stimulation to strengthen pelvic floor musculature and improve bladder control in men with post-prostatectomy incontinence. Daily home ...
The first patients have been treated in WOLVERINE, a prospective feasibility trial of the Edison Histotripsy System for BPH. The first patients have been treated in the WOLVERINE study (NCT07214675), ...
At 3 years, transdermal estradiol demonstrated noninferior MFS compared with standard LHRH agonists. A large phase 3 randomized trial has demonstrated that transdermal estradiol (tE2) patches are ...
IDMC review at the 50% evaluable milestone (n=183) concluded no additional accrual is needed to preserve protocol-specified power for the primary end point of CR rate. QUILT-2.005 is a randomized, ...
Noninvasive, anesthesia-free Break Wave ultrasound lithotripsy received 510(k) clearance, supported by the SOUND pivotal trial, and can pair with Stone Clear to aid fragment clearance. VYBRIQUE, an ...
Pylarify TruVu (piflufolastat F18) was approved as a reformulated PSMA-PET agent with improved stability at higher activity, enabling broader distribution and anticipated Q4 2026 availability. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results